Merck

Merck Earns Place on 2018 List of Top Companies for Executive Women

Press Release

KENILWORTH, N.J., March 9, 2018 /3BL Media/ -- The National Association for Female Executives (NAFE) named Merck as one of its 2018 NAFE Top Companies for Executive Women. The award recognizes U.S. corporations where women have significant clout to make the decisions that affect their company’s future and its bottom line. The NAFE Top 70 Companies are featured in the April/May issue of Working Mother.

Looking Beyond Next Quarter’s Results, 5 Global CEOs Share Long-Term Strategic Plans

To end “short-termism” on Wall Street, CEOs present plans for 3+ years out to investors representing $25 trillion in AUM
Press Release

NEW YORK, February 28, 2018 /3BL Media/ - CEOs from some of the most prominent companies in the world--including Johnson & Johnson, Medtronic, Merck, Unilever, and UPS -- came together to share their long-term business plans to an audience of more than 275 major institutional investors at the third CEO Investor Forum (CIF) organized by the CECP’s Strategic Investor Initiative (SII).

Ferring Pharmaceuticals and Merck Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Hemorrhage

Summary: 
  • Excessive Bleeding after Childbirth (Postpartum Hemorrhage or PPH) is the Leading Direct Cause of Maternal Mortality Worldwide
     
  • The CHAMPION Trial is Assessing the Effectiveness and Safety of Heat-Stable Carbetocin versus Oxytocin, the Current Standard of Care, for Preventing PPH After Vaginal Birth
Press Release
  • Excessive Bleeding after Childbirth (Postpartum Hemorrhage or PPH) is the Leading Direct Cause of Maternal Mortality Worldwide
     
  • The CHAMPION Trial is Assessing the Effectiveness and Safety of Heat-Stable Carbetocin versus Oxytocin, the Current Standard of Care, for Preventing PPH After Vaginal Birth

Merck for Mothers Blog | A Note from Dr. Etiebet: Reflections from WEF 2018

Blog

The MSD for Mothers team recently returned from the World Economic Forum annual meeting in Davos, where we joined leaders from business, government, civil society and academia in discussions around the theme, “Creating a Shared Future in a Fractured World.” In keeping with the focus on the global economy, MSD for Mothers and our partners made the business case for investing in maternal health, argued for greater private sector involvement in innovative financing for development, and advocated for more research on the experiences of wome

Fortune Magazine Names Merck One of World’s Most Admired Companies

Multimedia with summary

Fortune Magazine has released its annual list of the World’s Most Admired Companies. For the first time, Merck ranked first among its peers for pioneering innovation and second overall among pharmaceutical industry in the survey.

“We are honored to be recognized on Fortune’s list of Most Admired Companies,” says Ken Frazier, chairman and CEO, Merck.  “This ranking reflects our strategic focus and relentless passion for inventing new ways to save and improve lives.”

Healthcare Businesswomen’s Association (HBA) Recognizes Merck's Dr. Julie Gerberding for Significant Contributions to Health Care

Article

Dr. Julie L. Gerberding, M.D., M.P.H., Executive Vice President & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health for Merck, has been named the Healthcare Businesswomen’s Association (HBA) 2018 Woman of the Year.

Merck for Mothers 2017: A Year in Review

Multimedia with summary

As 2017 draws to a close, we wanted to reflect and celebrate the progress we've made – alongside our partners and maternal health champions – toward creating a world where no woman dies while giving life. We can end preventable maternal deaths in our lifetime, but we can't do it alone. We want to thank all who have supported our initiative this year, from championing quality health for mothers across the globe, to partnering together to find inventive solutions to move the needle on this global challenge.

Merck for Mothers Proudly Announces Partnership with USAID to Launch the World’s First Healthcare Development Impact Bond

Multimedia with summary

The Utkrisht Impact Bond – so named for the Hindi expression for ‘Excellence’ – is the world’s first health impact bond. It was developed by partners including USAID, Merck for Mothers, the UBS Optimus Foundation, PSI, Palladium, and HLFPPT.

Merck Commemorates 30 Years of MECTIZAN® Donation Program Progress

Program Expanded to Reach Additional 100 Million People Annually for Lymphatic Filariasis in Support of New, Evidence-Based WHO Guidelines
Press Release

KENILWORTH, N.J., November 30, 2017 /3BL Media/ -- Today, Merck announced an expansion of the MECTIZAN® Donation Program (MDP) to reach up to an additional 100 million people per year through 2025 as part of the global effort to eliminate lymphatic filariasis (LF).

Pages

Subscribe to Merck